Literature DB >> 2872054

Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.

B Silke, M A Frais, S P Verma, G Reynolds, S H Taylor.   

Abstract

Theoretically the increased sympathoadrenal activity following acute myocardial infarction might augment the haemodynamic impact of beta-adrenoceptor blockade. To evaluate this question 32 haemodynamic studies were performed to compare the effects of equivalent beta-blocking doses of propranolol (8 mg i.v.) and pindolol (0.8 mg i.v.) in patients with a recent acute myocardial infarction (A.M.I.) or stable coronary artery disease (and a presumptive low sympathetic state). In stable coronary artery disease there were clear differences between the haemodynamic impact of propranolol and pindolol. Propranolol decreased both heart rate (delta HR -7 beat/min) and cardiac index (delta CI -0.4 l/min/m2), with an increased pulmonary artery occluded pressure (delta PAOP +4 mmHg) and systemic vascular resistance index (delta SVRI +358 dyn X s X cm-5 m2). However an equivalent beta-blocking dose of pindolol increased PAOP (delta PAOP +3 mmHg) leaving other variables unchanged. These differential actions of propranolol and pindolol have previously been ascribed to the intrinsic sympathomimetic activity (I.S.A.) of pindolol maintaining cardiac pumping function in a low sympathetic state. In contrast following myocardial infarction, both drugs reduced cardiac index to a significantly greater extent compared with stable coronary artery disease (delta CI propranolol -0.81/min/m2; pindolol -0.4 l/min/m2; p less than 0.05); propranolol also reduced the systemic arterial blood pressure (delta systolic -10 mmHg; delta mean -5 mmHg; p less than 0.05). The haemodynamic relevance of the I.S.A. of pindolol appeared attenuated following A.M.I. These data are compatible with experimental evidence of sympathetic nervous activation following coronary occlusion; the resulting hyperadrenergic state appears to condition an augmented haemodynamic response to beta-blocking drugs irrespective of their ancillary pharmacological properties.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872054     DOI: 10.1007/bf00615955

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  33 in total

1.  Inhibition by -blockade of the ST segment elevation after acute myocardial infarction in man.

Authors:  L J Pelides; D S Reid; M Thomas; J P Shillingford
Journal:  Cardiovasc Res       Date:  1972-05       Impact factor: 10.787

2.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

3.  Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease.

Authors:  S H Taylor; B Silke; P S Lee; A Hilal
Journal:  Eur Heart J       Date:  1982-12       Impact factor: 29.983

4.  Cardiac dose-response relationships of oral and intravenous pindolol.

Authors:  S G Carruthers
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction.

Authors:  C Valori; M Thomas; J Shillingford
Journal:  Am J Cardiol       Date:  1967-11       Impact factor: 2.778

6.  Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.

Authors:  R Lochan; B Silke; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

7.  Electrocardiographic surface mapping of the heart following myocardial infarction and the influence of beta-blockade.

Authors:  D S Reid; L J Pelides; J P Shillingford; M Thomas
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

8.  Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction.

Authors:  B Silke; G I Nelson; R C Ahuja; C Walker; S H Taylor
Journal:  Int J Cardiol       Date:  1984-03       Impact factor: 4.164

9.  Haemodynamic effects of propranolol (Inderal) in acute myocardial infarction.

Authors:  G Bay; P Lund-Larsen; E Lorentsen; E Sivertssen
Journal:  Br Med J       Date:  1967-01-21

10.  Protective effect of propranolol in threatened myocardial infarction.

Authors:  R M Norris; E D Clarke; N L Sammel; W M Smith; B Williams
Journal:  Lancet       Date:  1978-10-28       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.